Sumathy Puvanendiran, Ph.D.
Affiliations: | 2011 | Veterinary Medicine | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Veterinary Science, MicrobiologyGoogle:
"Sumathy Puvanendiran"Parents
Sign in to add mentor| Michael P. Murtaugh | grad student | 2011 | UMN | |
| (Porcine Circovirus 2 Prevalence and Host-cell Interaction.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dvorak CMT, Puvanendiran S, Murtaugh MP. (2018) Porcine circovirus 2 infection induces IFNβ expression through increased expression of genes involved in RIG-I and IRF7 signaling pathways. Virus Research |
| Sivakumar T, Kothalawala H, Weerasooriya G, et al. (2016) A longitudinal study of Babesia and Theileria infections in cattle in Sri Lanka. Veterinary Parasitology, Regional Studies and Reports. 6: 20-27 |
| Dvorak CM, Puvanendiran S, Murtaugh MP. (2013) Cellular pathogenesis of porcine circovirus type 2 infection. Virus Research. 174: 60-8 |
| Haley C, Wagner B, Puvanendiran S, et al. (2011) Diagnostic performance measures of ELISA and quantitative PCR tests for porcine circovirus type 2 exposure using Bayesian latent class analysis. Preventive Veterinary Medicine. 101: 79-88 |
| Patterson AR, Johnson JK, Ramamoorthy S, et al. (2011) Interlaboratory comparison of Porcine circovirus-2 indirect immunofluorescent antibody test and enzyme-linked immunosorbent assay results on experimentally infected pigs. Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. 23: 206-12 |
| Puvanendiran S, Stone S, Yu W, et al. (2011) Absence of porcine circovirus type 1 (PCV1) and high prevalence of PCV 2 exposure and infection in swine finisher herds. Virus Research. 157: 92-8 |
| Prickett JR, Johnson J, Murtaugh MP, et al. (2011) Prolonged detection of PCV2 and anti-PCV2 antibody in oral fluids following experimental inoculation. Transboundary and Emerging Diseases. 58: 121-7 |